Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$341M |
| 2 |
GE Vernova
GEV
|
+$336M |
| 3 |
SW
Smurfit Westrock
SW
|
+$332M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$331M |
| 5 |
Omnicom Group
OMC
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.29B |
| 2 |
Microsoft
MSFT
|
+$1.03B |
| 3 |
NVIDIA
NVDA
|
+$903M |
| 4 |
Apple
AAPL
|
+$611M |
| 5 |
Eli Lilly
LLY
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.39% |
| 2 | Financials | 12.04% |
| 3 | Healthcare | 11.84% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Quantum-Si Incorporated
QSI
$172M
| $196K | ﹤0.01% |
222,407
-100,053
| -31% | -$97.1K |
|
3802
Caesarstone
CSTE
$105M
| $196K | ﹤0.01% |
42,993
-15,576
| -27% | -$78.4K |
|
3803
Ovid Therapeutics
OVID
$523M
| $196K | ﹤0.01% |
165,763
-52,400
| -24% | -$54.7K |
|
3804
Provident Financial
PROV
$113M
| $195K | ﹤0.01% |
13,601
+1
| +0% | +$13 |
|
3805
Garrett Motion
GTX
$5.35B
| $193K | ﹤0.01% |
23,634
-10,261
| -30% | -$86.3K |
|
3806
Kimbell Royalty Partners
KRP
$1.52B
| $192K | ﹤0.01% |
11,902
-250
| -2% | -$4.03K |
|
3807
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $191K | ﹤0.01% |
19,002
| – | – |
|
|
SBDS
3808
DELISTED
Solo Brands Inc
SBDS
| $191K | ﹤0.01% |
3,387
-350
| -9% | -$24.9K |
|
3809
Northern Technologies International Corp
NTIC
$76.7M
| $186K | ﹤0.01% |
15,122
-5,475
| -27% | -$72.3K |
|
3810
ThredUp
TDUP
$416M
| $185K | ﹤0.01% |
220,008
-54,791
| -20% | -$67K |
|
3811
Hyperfine
HYPR
$94.7M
| $185K | ﹤0.01% |
171,495
| – | – |
|
3812
Anixa Biosciences
ANIX
$109M
| $185K | ﹤0.01% |
58,745
-14,305
| -20% | -$44K |
|
3813
Empire Petroleum
EP
$111M
| $185K | ﹤0.01% |
35,225
-9,767
| -22% | -$50.3K |
|
3814
NLI Holdings
NL
$319M
| $185K | ﹤0.01% |
24,844
-6,651
| -21% | -$42.7K |
|
3815
Flotek Industries
FTK
$1.25B
| $185K | ﹤0.01% |
37,049
| – | – |
|
3816
Invivyd
IVVD
$202M
| $184K | ﹤0.01% |
180,758
-58,615
| -24% | -$63.5K |
|
|
RAPT
3817
DELISTED
RAPT Therapeutics
RAPT
| $181K | ﹤0.01% |
11,276
-3,048
| -21% | -$61.6K |
|
3818
Century Therapeutics
IPSC
$349M
| $181K | ﹤0.01% |
105,994
-43,006
| -29% | -$84.3K |
|
3819
Skye Bioscience
SKYE
$19M
| $176K | ﹤0.01% |
44,907
-13,871
| -24% | -$77.8K |
|
3820
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.09B
| $174K | ﹤0.01% |
+20,002
| New | +$168K |
|
3821
908 Devices
MASS
$418M
| $173K | ﹤0.01% |
49,930
-19,620
| -28% | -$87K |
|
3822
BlackRock Resources & Commodities Strategy Trust
BCX
$961M
| $173K | ﹤0.01% |
+18,003
| New | +$166K |
|
3823
OP Bancorp
OPBK
$235M
| $172K | ﹤0.01% |
13,781
-1
| -0% | -$12 |
|
|
CODX
3824
Co-Diagnostics
CODX
$5.49M
| $171K | ﹤0.01% |
4,569
| – | – |
|
3825
Neuropace
NPCE
$498M
| $169K | ﹤0.01% |
24,209
-9,850
| -29% | -$72K |
|
Similar funds
Bank of New York Mellon's Q3 2024 Portfolio in Review
As of Q3 2024, Bank of New York Mellon held 4,226 positions worth $538B, up 1.9% from $528B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Bank of New York Mellon withdrew a net $19.5B in Q3 2024, closing 133 positions and reducing 3,139 holdings. Its most notable exit was WestRock Company, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in Smurfit Westrock worth $361M.
- Bank of New York Mellon's largest Q3 2024 buy was Smurfit Westrock: 7,304,149 shares worth $361M.
- Bank of New York Mellon added most to Visa in Q3 2024, an estimated $341M increase.
- Bank of New York Mellon's biggest Q3 2024 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.29B.
- Bank of New York Mellon fully exited WestRock Company in Q3 2024, selling an estimated $112M.
- Bank of New York Mellon's ten largest holdings make up 24% of its $538B portfolio in Q3 2024.
- Bank of New York Mellon opened 105 new positions and closed 133 in Q3 2024.
- Bank of New York Mellon's portfolio value rose 1.9% quarter-over-quarter to $538B.
Based on Bank of New York Mellon's 13F filing for Q3 2024, filed 12 Nov 2024.